TRACON Pharmaceutical (TCON) Tops Q4 EPS by 23c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q4 EPS of $, $0.23 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SanDisk upgraded at JPMorgan after investor day; shares climb